Funding · Company
ECM Therapeutics, Inc.
Warrendale, PABiotech & Pharma
ECM Therapeutics, Inc. of Warrendale, PA has disclosed $35M across 1 Form D offering filed with the SEC on Oct 10, 2025.
$35M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$35M
Form D · Oct 10, 2025 ↗
Q4 2025
· 4 amendments, first filed Jul 30, 2021
· target $40M
Filing details
HeadquartersWarrendale, PAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001743104Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →